⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 28, 2026Biomarkers in Medicine

Clarifying the incremental value and implementation boundaries of combined pct and IL-6 in sepsis risk stratification

Yu Qi Guo‐Ming Zhang

View Full Paper

Ask AI

Bookmark

Share

Abstract

We read with interest the study by Xia et al. which evaluated the early prognostic value of combined procalcitonin (PCT) and interleukin-6 (IL-6) in patients with sepsis [1]. This topic is clini...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Qi et al. (2026) studied this question.

synapsesocial.com/papers/6abdf7bb66f3754618514eb6 https://doi.org/10.1080/17520363.2026.2739532

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Early prognostic value of combined procalcitonin and interleukin-6 in sepsis: a retrospective cohort studyCohort Study · 2026 · 1 citations
2Procalcitonin and interleukin-6 in predicting prognosis of sepsis patients with cancer2024
3Elevations in presepsin, PCT, hs-CRP, and IL-6 levels predict mortality among septic patients in the ICU2024 · 19 citations
4Diagnostic and Prognostic Value of Pentraxin 3, Interleukin-6, CRP, and Procalcitonin Levels in Patients with Sepsis and Septic Shock2024 · 11 citations
5Usefulness of neutrophil-to-lymphocyte count ratio, procalcitonin, and interleukin-6 for severity assessment of bacterial sepsis2024 · 1 citations